Use of Autologous Bacteriotherapy to Treat Staphylococcus aureus in Patients With Atopic Dermatitis | Zendy

Teruaki Nakatsuji | Zendy; Richard L. Gallo | Zendy; Faiza Shafiq | Zendy; Yun Tong | Zendy; Kimberly Chun | Zendy; Anna M. Butcher | Zendy; J Cheng | Zendy; Tissa Hata | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Use of Autologous Bacteriotherapy to Treat Staphylococcus aureus in Patients With Atopic Dermatitis

Author(s) -

Teruaki Nakatsuji,

Richard L. Gallo,

Faiza Shafiq,

Yun Tong,

Kimberly Chun,

Anna M. Butcher,

J Cheng,

Tissa Hata

Publication year - 2021

Publication title -

jama dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.128

H-Index - 166

eISSN - 2168-6084

pISSN - 2168-6068

DOI - 10.1001/jamadermatol.2021.1311

Subject(s) - medicine , staphylococcus aureus , atopic dermatitis , cons , adverse effect , randomized controlled trial , staphylococcal infections , clinical trial , clinical endpoint , dermatology , surgery , genetics , bacteria , computer science , biology , programming language

Atopic dermatitis (AD) can be negatively affected by Staphylococcus aureus. The skin microbiome of AD is deficient in coagulase-negative Staphylococcus (CoNS) that can kill S aureus.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research